Fluxid

Active Ingredient(s): Famotidine
FDA Approved: * September 24, 2004
Pharm Company: * SCHWARZ PHARMA
Category: Heart Burn / Indigestion

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Fluxid Overview

Famotidine, sold under the trade name Pepcid among others, is a histamine H2 receptor antagonist that inhibits stomach acid production. It is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. Unlike cimetidine, the first H2 antagonist, famotidine has no effect on the cytochrome P450 enzyme system, and does not appear to interact with other drugs.[2] It was discovered in 1979.[3] Contents 1 Medical uses 1.1 Prepara...

Read more Fluxid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Famotidine

Recent Fluxid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Famotidine
  • For Suspension: 40mg/5ml
  • Granule: 40mg/5ml
  • Injection: 10mg/ml, 20mg/50ml
  • Suspension: 40mg/5ml
  • Tablet: 10mg, 20mg, 40mg
  • Tablet, Chewable: 10mg, 20mg
  • Tablet, Orally Disintegrated: 20mg, 40mg
  • Tablet, Orally Disintegrating: 20mg, 40mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Fluxid: (2 results)

Sorted by National Drug Code
  • 0091-3371 Fluxid 20 mg Disintegrating Tablet by Schwarz Pharma
  • 0091-3372 Fluxid 40 mg Disintegrating Tablet by Schwarz Pharma

Other drugs which contain Famotidine or a similar ingredient: (12 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA